Literature DB >> 22532526

A putative role for the immunoproteasome in the maintenance of pluripotency in human embryonic stem cells.

Stuart P Atkinson1, Joseph Collin, Neganova Irina, George Anyfantis, Bo Kim Kyung, Majlinda Lako, Lyle Armstrong.   

Abstract

The function of the proteasome is essential for maintenance of cellular homeostasis, and in pluripotent stem cells, this has been extended to the removal of nascent proteins in a manner that restricts differentiation. In this study, we show enhanced expression of genes encoding subunits of the 20S proteasome in human embryonic stem cells (hESCs) coupled to their downregulation as the cells progress into differentiation. The decrease in expression is particularly marked for the alternative catalytic subunits of the 20S proteasome variant known as the immunoproteasome indicating the possibility of a hitherto unknown function for this proteasome variant in pluripotent cells. The immunoproteasome is normally associated with antigen-presenting cells where it provides peptides of an appropriate length for antibody generation; however, our data suggest that it may be involved in maintaining the pluripotency in hESCs. Selective inhibition of two immunoproteasome subunits (PSMB9 and PSMB8) results in downregulation of cell surface and transcriptional markers that characterize the pluripotent state, subtle cell accumulation in G1 at the expense of S-phase, and upregulation of various markers characterizing the differentiated primitive and definitive lineages arising from hESC. Our data also support a different function for each of these two subunits in hESC that may be linked to their selectivity in driving proteasome-mediated degradation of cell cycle regulatory components and/or differentiation inducing factors.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532526     DOI: 10.1002/stem.1113

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  18 in total

1.  Prolonged proteasome inhibition cyclically upregulates Oct3/4 and Nanog gene expression, but reduces induced pluripotent stem cell colony formation.

Authors:  Z Elizabeth Floyd; Elizabeth Z Floyd; Jaroslaw Staszkiewicz; Rachel A Power; Gail Kilroy; Heather Kirk-Ballard; Christian W Barnes; Karen L Strickler; Jong S Rim; Lettie L Harkins; Ru Gao; Jeong Kim; Kenneth J Eilertsen
Journal:  Cell Reprogram       Date:  2015-04       Impact factor: 1.987

Review 2.  Emerging role of immunoproteasomes in pathophysiology.

Authors:  Gagandeep Kaur; Sanjay Batra
Journal:  Immunol Cell Biol       Date:  2016-06-14       Impact factor: 5.126

3.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

4.  Siah2 Protein Mediates Early Events in Commitment to an Adipogenic Pathway.

Authors:  Gail Kilroy; David H Burk; Z Elizabeth Floyd
Journal:  J Biol Chem       Date:  2016-11-18       Impact factor: 5.157

5.  Nrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cells.

Authors:  Jiwon Jang; Yidi Wang; Hyung-Seok Kim; Matthew A Lalli; Kenneth S Kosik
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

6.  A FRET-based approach for identification of proteasome catalytic subunit composition.

Authors:  Ji Eun Park; Ying Wu; Kimberly Cornish Carmony; Zachary Miller; Lalit Kumar Sharma; Do-Min Lee; Doo-Young Kim; Wooin Lee; Kyung-Bo Kim
Journal:  Mol Biosyst       Date:  2014-02

Review 7.  Inhibitors of the immunoproteasome: current status and future directions.

Authors:  Zachary Miller; Lin Ao; Kyung Bo Kim; Wooin Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases.

Authors:  Isabel Saez; David Vilchez
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

Review 9.  The proteasome complex and the maintenance of pluripotency: sustain the fate by mopping up?

Authors:  Friederike Schröter; James Adjaye
Journal:  Stem Cell Res Ther       Date:  2014-02-18       Impact factor: 6.832

10.  Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling.

Authors:  Marcela Maldonado; Rebecca J Kapphahn; Marcia R Terluk; Neal D Heuss; Ching Yuan; Dale S Gregerson; Deborah A Ferrington
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.